Home LiteratureArticle Details
PMID: 10073973 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Induction of monocyte binding to endothelial cells by MM-LDL: role of lipoxygenase metabolites.

Arteriosclerosis, thrombosis, and vascular biology ·Vol. 19 ·No. 3 ·1999-03-00 ·Pages 680-6

Honda HM, Leitinger N, Frankel M, Goldhaber JI, Natarajan R, Nadler JL, Weiss JN, Berliner JA

Abstract

Treatment of human aortic endothelial cells (EC) with minimally oxidized LDL (or minimally modified LDL, MM-LDL) produces a specific pattern of endothelial cell activation distinct from that produced by LPS, tumor necrosis factor-alpha, and interleukin-1, but similar to other agents that elevate cAMP. The current studies focus on the signal transduction pathways by which MM-LDL activates EC to bind monocytes. We now demonstrate that, in addition to an elevation of cAMP, lipoxygenase products are necessary for the MM-LDL response. Treatment of EC with inhibitors of the lipoxygenase pathway, 5,8,11, 14-eicosatetraynoic acid (ETYA) or cinnamyl-3, 4-dihydroxy-alpha-cyanocinnamate (CDC), blocked monocyte binding in MM-LDL-treated EC (MM-LDL=118+/-13%; MM-LDL+ETYA=33+/-4%; MM-LDL+CDC=23+/-4% increase in monocyte binding) without reducing cAMP levels. To further investigate the role of the lipoxygenase pathway, cellular phospholipids were labeled with arachidonic acid. Treatment of cells for 4 hours with 50 to 100 microg/mL MM-LDL, but not native LDL, caused a 60% increase in arachidonate release into the medium and increased the intracellular formation of 12(S)-HETE (approximately 100% increase). There was little 15(S)-HETE present, and no increase in its levels was observed. We demonstrated that 12(S)-HETE reversed the inhibitory effect of CDC. We also observed a 70% increase in the formation of 11,12-epoxyeicosatrienoic acid (11, 12-EET) in cells treated with MM-LDL. To determine the mechanism of arachidonate release induced by MM-LDL, we examined the effects of MM-LDL on intracellular calcium levels. Treatment of EC with both native LDL and MM-LDL caused a rapid release of intracellular calcium from internal stores. However, several pieces of evidence suggest that calcium release alone does not explain the increased arachidonate release in MM-LDL-treated cells. The present studies suggest that products of 12-lipoxygenase play an important role in MM-LDL action on the induction of monocyte binding to EC.

MeSH Terms
12-Hydroxy-5,8,10,14-eicosatetraenoic Acid/pharmacology Aorta/cytology Arachidonic Acid/metabolism,pharmacology Calcium/analysis,metabolism Cell Adhesion/drug effects,physiology Chelating Agents/pharmacology Cholesterol, LDL/metabolism Cyclic AMP/metabolism Cyclooxygenase Inhibitors/pharmacology Egtazic Acid/pharmacology Endothelium, Vascular/cytology,drug effects,enzymology Humans Lipoproteins, LDL/pharmacology Lipoxygenase/metabolism Monocytes/cytology,enzymology
Chemicals
Chelating Agents Cholesterol, LDL Cyclooxygenase Inhibitors Lipoproteins, LDL oxidized low density lipoprotein Arachidonic Acid Egtazic Acid 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid Cyclic AMP Lipoxygenase Calcium
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Honda H M
Department of Medicine (Cardiology), Physiology, and Pathology and Laboratory Medicine, Cardiovascular Research Laboratory, University of California at Los Angeles, CA, USA. [email protected]
Leitinger N
Frankel M
Goldhaber J I
Natarajan R
Nadler J L
Weiss J N
Berliner J A
Article Info
Journal
Arteriosclerosis, thrombosis, and vascular biology
Abbr.
Arterioscler Thromb Vasc Biol
ISSN
1079-5642
Published
1999-03-00
Pages
680-6
Language
English
Region
United States
NLM ID
9505803
Subset
IM
Grants
NHLBI NIH HHS · HL-30568 · United States
NHLBI NIH HHS · P01-HL-55798 · United States
NHLBI NIH HHS · R01-HL-44880 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]